Literature DB >> 27666764

Low-grade Schwann cell neoplasms with leptomeningeal dissemination: clinicopathologic and autopsy findings.

Erika F Rodriguez1, Jaishri Blakeley2, Shannon Langmead3, Alessandro Olivi4, Anthony Tufaro5, Abeer Tabbarah1, Gail Berkenblit6, Justin M Sacks5, Scott D Newsome3, Elizabeth Montgomery7, Fausto J Rodriguez8.   

Abstract

Leptomeningeal dissemination of low-grade Schwann cell neoplasms is an exceptionally rare occurrence and has not been well documented in the literature. We encountered 2 cases of leptomeningeal dissemination of low-grade Schwann cell neoplasms. Patient 1 was a 63-year-old woman with neurofibromatosis type 1 and a progressive low-grade malignant peripheral nerve sheath tumor developing from a diffuse/plexiform orbital neurofibroma that arose in childhood. The neoplasm demonstrated local and leptomeningeal dissemination intracranially leading to the patient's death. There was partial loss of H3K27 tri-methylation, p16 and collagen IV. Patient 2 was a 60-year-old man without neurofibromatosis type 1 who presented with cranial nerve symptoms and a disseminated neoplasm with a Schwann cell phenotype. The neoplasm stabilized after irradiation and chemotherapy, but the patient died of medical complications. Autopsy findings documented disseminated leptomeningeal disease in the intracranial and spinal compartment. H3K27M tri-methylation was preserved. The clinicopathologic and autopsy findings are studied and presented, and the literature is reviewed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MPNST; NF1; Neurofibroma; Neurofibromatosis; Schwann cell; Schwannoma

Mesh:

Substances:

Year:  2016        PMID: 27666764      PMCID: PMC5285484          DOI: 10.1016/j.humpath.2016.08.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  21 in total

1.  Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.

Authors:  Eline Beert; Hilde Brems; Bruno Daniëls; Ivo De Wever; Frank Van Calenbergh; Joseph Schoenaers; Maria Debiec-Rychter; Olivier Gevaert; Thomas De Raedt; Annick Van Den Bruel; Thomy de Ravel; Karen Cichowski; Lan Kluwe; Victor Mautner; Raf Sciot; Eric Legius
Journal:  Genes Chromosomes Cancer       Date:  2011-08-24       Impact factor: 5.006

2.  Primary malignant peripheral nerve sheath tumor of the spine with acute hydrocephalus: a rare clinical entity.

Authors:  Yaxiong Li; Fengshi Fan; Jianguo Xu; Jie An; Weining Zhang
Journal:  J Neurosurg Spine       Date:  2014-06-13

3.  Methylation-based classification of benign and malignant peripheral nerve sheath tumors.

Authors:  Manuel Röhrich; Christian Koelsche; Daniel Schrimpf; David Capper; Felix Sahm; Annekathrin Kratz; Jana Reuss; Volker Hovestadt; David T W Jones; Melanie Bewerunge-Hudler; Albert Becker; Joachim Weis; Christian Mawrin; Michel Mittelbronn; Arie Perry; Victor-Felix Mautner; Gunhild Mechtersheimer; Christian Hartmann; Ali Fuat Okuducu; Mirko Arp; Marcel Seiz-Rosenhagen; Daniel Hänggi; Stefanie Heim; Werner Paulus; Jens Schittenhelm; Rezvan Ahmadi; Christel Herold-Mende; Andreas Unterberg; Stefan M Pfister; Andreas von Deimling; David E Reuss
Journal:  Acta Neuropathol       Date:  2016-02-08       Impact factor: 17.088

4.  Schwannomas of the sinonasal tract and nasopharynx.

Authors:  S L Hasegawa; T Mentzel; C D Fletcher
Journal:  Mod Pathol       Date:  1997-08       Impact factor: 7.842

5.  Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.

Authors:  Reinhard E Friedrich; Karim Gawad; Thorsten Derlin; Jozef Zustin; Christian Hagel
Journal:  Anticancer Res       Date:  2012-10       Impact factor: 2.480

6.  Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.

Authors:  Arjen H G Cleven; Ghadah A Al Sannaa; Inge Briaire-de Bruijn; Davis R Ingram; Matt van de Rijn; Brian P Rubin; Maurits W de Vries; Kelsey L Watson; Keila E Torres; Wei-Lien Wang; Sjoerd G van Duinen; Pancras C W Hogendoorn; Alexander J Lazar; Judith V M G Bovée
Journal:  Mod Pathol       Date:  2016-03-18       Impact factor: 7.842

7.  Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.

Authors:  Carlos N Prieto-Granada; Thomas Wiesner; Jane L Messina; Achim A Jungbluth; Ping Chi; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

8.  Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors.

Authors:  Ming Zhang; Yuxuan Wang; Sian Jones; Mark Sausen; Kevin McMahon; Rajni Sharma; Qing Wang; Allan J Belzberg; Kaisorn Chaichana; Gary L Gallia; Ziya L Gokaslan; Greg J Riggins; Jean-Paul Wolinksy; Laura D Wood; Elizabeth A Montgomery; Ralph H Hruban; Kenneth W Kinzler; Nickolas Papadopoulos; Bert Vogelstein; Chetan Bettegowda
Journal:  Nat Genet       Date:  2014-10-12       Impact factor: 38.330

9.  Malignant peripheral nerve sheath tumors of the orbit: a clinicopathologic study of eight cases.

Authors:  F A Jakobiec; R L Font; L E Zimmerman
Journal:  Trans Am Ophthalmol Soc       Date:  1985

10.  PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.

Authors:  William Lee; Sewit Teckie; Thomas Wiesner; Leili Ran; Carlos N Prieto Granada; Mingyan Lin; Sinan Zhu; Zhen Cao; Yupu Liang; Andrea Sboner; William D Tap; Jonathan A Fletcher; Kety H Huberman; Li-Xuan Qin; Agnes Viale; Samuel Singer; Deyou Zheng; Michael F Berger; Yu Chen; Cristina R Antonescu; Ping Chi
Journal:  Nat Genet       Date:  2014-09-21       Impact factor: 38.330

View more
  5 in total

1.  Clinicopathological features of peripheral nerve sheath tumors involving the eye and ocular adnexa.

Authors:  Mingjuan L Zhang; Maria J Suarez; Thomas M Bosley; Fausto J Rodriguez
Journal:  Hum Pathol       Date:  2017-02-22       Impact factor: 3.466

2.  Intracranial cellular schwannomas: a clinicopathological study of 20 cases.

Authors:  Felipe D'Almeida Costa; Tiago M Dias; Kara A Lombardo; Aditya Raghunathan; Caterina Giannini; Lawrence Kenyon; Ali G Saad; Murat Gokden; Peter C Burger; Elizabeth A Montgomery; Fausto J Rodriguez
Journal:  Histopathology       Date:  2019-11-13       Impact factor: 5.087

3.  Pediatric midline H3K27M-mutant tumor with disseminated leptomeningeal disease and glioneuronal features: case report and literature review.

Authors:  Ralph E Navarro; Danielle Golub; Travis Hill; Michelle W McQuinn; Christopher William; David Zagzag; Eveline Teresa Hidalgo
Journal:  Childs Nerv Syst       Date:  2020-09-28       Impact factor: 1.475

4.  Differential gene methylation and expression of HOX transcription factor family in orbitofacial neurofibroma.

Authors:  Antje Arnold; Eddie Luidy Imada; M Lisa Zhang; Deepak P Edward; Luigi Marchionni; Fausto J Rodriguez
Journal:  Acta Neuropathol Commun       Date:  2020-05-04       Impact factor: 7.801

5.  RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.

Authors:  Eddie Luidy Imada; Diego Strianese; Deepak P Edward; Rawan alThaqib; Antionette Price; Antje Arnold; Hailah Al-Hussain; Luigi Marchionni; Fausto J Rodriguez
Journal:  Brain Pathol       Date:  2021-07-23       Impact factor: 6.508

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.